We have located links that may give you full text access.
CLINICAL TRIAL
JOURNAL ARTICLE
OBSERVATIONAL STUDY
Neutrophil, Lymphocyte, and Platelet Counts and Acute Kidney Injury After Cardiovascular Surgery.
Journal of Cardiothoracic and Vascular Anesthesia 2018 Februrary
OBJECTIVE: Postoperative low platelet count and perioperative high neutrophil/lymphocyte (N/L) ratio are associated with acute kidney injury (AKI) and mortality after cardiac surgery. The authors investigated whether (1) their combination neutrophil/lymphocyte × platelet (N/LP) ratio is an independent predictor of AKI and postoperative mortality and (2) whether the N/LP ratio increases predictive ability compared with the N/L ratio or platelet nadir.
DESIGN: This was a retrospective and observational study.
SETTING: Single large university hospital.
PARTICIPANTS: The study comprised 1,099 adult patients who underwent cardiovascular surgeries with cardiopulmonary bypass.
MEASUREMENTS AND MAIN RESULTS: Baseline clinical parameters including platelet counts, the N/L ratio, and the N/LP ratio measured before surgery, immediately after surgery, and on postoperative days 1 and 2 were obtained. Multivariable analysis revealed that the maximal N/LP ratio was an independent predictor of AKI and 5-year mortality. Propensity score matching was performed between the high and low preoperative N/LP ratio groups. Significant differences in the mortality rate and incidence of AKI also were found in the matched cohort. The area under the receiver operating characteristic curve (AUC) of the maximal N/LP ratio as a continuous variable was significantly higher than the AUC of the maximal N/L ratio or nadir platelet as continuous variables (maximal N/LP ratio: 0.62 v N/L ratio: 0.59; p = 0.026 v platelet nadir: 0.57; p = 0.003). The AUC of multivariable risk prediction with the maximal N/LP ratio (0.77) was significantly higher than the AUC without the N/LP ratio (0.70; p < 0.0001).
CONCLUSIONS: High N/LP ratios were associated with postoperative AKI and 5-year mortality. The N/LP ratio may assist with the the prediction of AKI and mortality in high-risk cardiovascular surgery.
DESIGN: This was a retrospective and observational study.
SETTING: Single large university hospital.
PARTICIPANTS: The study comprised 1,099 adult patients who underwent cardiovascular surgeries with cardiopulmonary bypass.
MEASUREMENTS AND MAIN RESULTS: Baseline clinical parameters including platelet counts, the N/L ratio, and the N/LP ratio measured before surgery, immediately after surgery, and on postoperative days 1 and 2 were obtained. Multivariable analysis revealed that the maximal N/LP ratio was an independent predictor of AKI and 5-year mortality. Propensity score matching was performed between the high and low preoperative N/LP ratio groups. Significant differences in the mortality rate and incidence of AKI also were found in the matched cohort. The area under the receiver operating characteristic curve (AUC) of the maximal N/LP ratio as a continuous variable was significantly higher than the AUC of the maximal N/L ratio or nadir platelet as continuous variables (maximal N/LP ratio: 0.62 v N/L ratio: 0.59; p = 0.026 v platelet nadir: 0.57; p = 0.003). The AUC of multivariable risk prediction with the maximal N/LP ratio (0.77) was significantly higher than the AUC without the N/LP ratio (0.70; p < 0.0001).
CONCLUSIONS: High N/LP ratios were associated with postoperative AKI and 5-year mortality. The N/LP ratio may assist with the the prediction of AKI and mortality in high-risk cardiovascular surgery.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app